Skip to main content
Premium Trial:

Request an Annual Quote

SomaLogic, New England Biolabs Partner on PCR Products

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – SomaLogic and New England Biolabs today announced an agreement for the provision of specific aptamer-based reagents to NEB for nucleic acid amplification and PCR products.

Under the terms of the deal, SomaLogic will provide certain SomaMers — which are specific protein binding reagents based on chemically modified aptamers developed by SomaLogic — to NEB to incorporate them into its products as reversible inhibitors of thermally active DNA polymerases used in PCR, the two firms said.

Financial and other terms of the agreement were not disclosed.

In a statement, Salvatore Russello, associate director of business development at NEB, said that there are many opportunities to improve the performance of thermally active DNA polymerase in PCR reactions.

"This agreement is thus of great value to NEB and is already being used to improve the application of DNA polymerases," such as NEB's OneTaq Hot Start product, he said.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.